Logo image of NLH.CA

NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis

Canada - TSX-V:NLH - CA66980G1090 - Common Stock

0.265 CAD
-0.01 (-1.85%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, NLH scores 4 out of 10 in our fundamental rating. NLH was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of NLH get a neutral evaluation. Nothing too spectacular is happening here. NLH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year NLH has reported negative net income.
In the past year NLH had a positive cash flow from operations.
In multiple years NLH reported negative net income over the last 5 years.
NLH had a positive operating cash flow in each of the past 5 years.
NLH.CA Yearly Net Income VS EBIT VS OCF VS FCFNLH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M 3M

1.2 Ratios

The Return On Assets of NLH (0.49%) is comparable to the rest of the industry.
NLH has a Return On Equity of 0.62%. This is in the better half of the industry: NLH outperforms 66.67% of its industry peers.
The Return On Invested Capital of NLH (3.34%) is better than 66.67% of its industry peers.
Industry RankSector Rank
ROA 0.49%
ROE 0.62%
ROIC 3.34%
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
NLH.CA Yearly ROA, ROE, ROICNLH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

NLH has a Profit Margin (0.41%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of NLH has declined.
Looking at the Operating Margin, with a value of 3.04%, NLH is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Gross Margin of NLH (39.13%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NLH has grown nicely.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.41%
GM 39.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
NLH.CA Yearly Profit, Operating, Gross MarginsNLH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NLH is destroying value.
NLH has more shares outstanding than it did 1 year ago.
NLH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NLH has a worse debt to assets ratio.
NLH.CA Yearly Shares OutstandingNLH.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NLH.CA Yearly Total Debt VS Total AssetsNLH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

NLH has an Altman-Z score of 3.23. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.23, NLH belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
NLH has a debt to FCF ratio of 2.32. This is a good value and a sign of high solvency as NLH would need 2.32 years to pay back of all of its debts.
The Debt to FCF ratio of NLH (2.32) is better than 86.67% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.32
Altman-Z 3.23
ROIC/WACC0.44
WACC7.5%
NLH.CA Yearly LT Debt VS Equity VS FCFNLH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

NLH has a Current Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
NLH has a Current ratio (0.82) which is in line with its industry peers.
NLH has a Quick Ratio of 0.82. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.82, NLH perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
NLH.CA Yearly Current Assets VS Current LiabilitesNLH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

NLH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.38%, which is quite good.
NLH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.19% yearly.
Looking at the last year, NLH shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
Measured over the past years, NLH shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NLH.CA Yearly Revenue VS EstimatesNLH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NLH.CA Yearly EPS VS EstimatesNLH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 0.01 0.02 0.03

2

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NLH.CA Price Earnings VS Forward Price EarningsNLH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NLH is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, NLH is valued a bit cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.69
EV/EBITDA 12
NLH.CA Per share dataNLH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NLH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NOVA LEAP HEALTH CORP

TSX-V:NLH (10/21/2025, 7:00:00 PM)

0.265

-0.01 (-1.85%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-06 2025-11-06
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap23.14M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF 11.69
P/OCF 11.48
P/B 0.88
P/tB 20.38
EV/EBITDA 12
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY8.56%
OCF(TTM)0.02
OCFY8.71%
SpS0.45
BVpS0.3
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.49%
ROE 0.62%
ROCE 4.39%
ROIC 3.34%
ROICexc 3.59%
ROICexgc 267.42%
OM 3.04%
PM (TTM) 0.41%
GM 39.13%
FCFM 5.02%
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score5
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.32
Debt/EBITDA 0.53
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.13
Cash Conversion 92.26%
Profit Quality 1214.21%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 3.23
F-Score5
WACC7.5%
ROIC/WACC0.44
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.27%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y-37.45%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%